Abstract
Background and Aims: No earlier study examined the association between adherence to the MIND (Mediterranean-DASH Diet Intervention for Neurodegenerative Delay) diet and odds of irritable bowel syndrome (IBS). This study was conducted to examine the relationship between adherence to the MIND diet and odds of IBS among Iranian adults. Methods: In this cross-sectional study, dietary intakes of 3,362 adults were examined using a validated Dish-Based 106-item Semi-Quantitative Food Frequency Questionnaire (DS-FFQ). The MIND diet score was constructed based on participants’ dietary intakes obtained from DS-FFQ. IBS was evaluated using a modified Persian version of the Rome III questionnaire. Results: Overall, 22.2% of the study population were affected by IBS (n = 748). We observed no significant relationship between adherence to the MIND diet and odds of IBS in the whole population (OR: 0.97; 95% CI: 0.71–1.31). By gender and BMI status, no significant association between adherence to the MIND diet and odds of IBS was seen. Also, no significant association was found between adherence to the MIND diet and IBS subtypes. Conclusion: No significant association was found between adherence to the MIND diet and odds of IBS. Further studies are needed to examine the association between dietary patterns and IBS.
References
1.
Canavan
C
, West
J
, Card
T
. The epidemiology of irritable bowel syndrome
. Clin Epidemiol
. 2014
;6
:71
–80
. .2.
Jahangiri
P
, Jazi
MS
, Keshteli
AH
, Sadeghpour
S
, Amini
E
, Adibi
P
. Irritable bowel syndrome in Iran: SEPAHAN systematic review no. 1
. Int J Prev Med
. 2012 Mar
;3
(Suppl 1
):S1
–9
.3.
Enck
P
, Aziz
Q
, Barbara
G
, Farmer
AD
, Fukudo
S
, Mayer
EA
, Irritable bowel syndrome
. Nat Rev Dis Primers
. 2016 Mar 24
;2
:16014
. .4.
Peery
AF
, Crockett
SD
, Murphy
CC
, Lund
JL
, Dellon
ES
, Williams
JL
, Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018
. Gastroenterology
. 2019 Jan
;156
(1
):254
–e11
. .5.
Bohn
L
, Storsrud
S
, Tornblom
H
, Bengtsson
U
, Simren
M
. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life
. Am J Gastroenterol
. 2013 May
;108
(5
):634
–41
.6.
Dionne
J
, Ford
AC
, Yuan
Y
, Chey
WD
, Lacy
BE
, Saito
YA
, A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of irritable bowel syndrome
. Am J Gastroenterol
. 2018 Sep
;113
(9
):1290
–300
. .7.
Elsenbruch
S
. Abdominal pain in irritable bowel syndrome: a review of putative psychological, neural and neuro-immune mechanisms
. Brain Behav Immun
. 2011 Mar
;25
(3
):386
–94
. .8.
Morris
MC
, Tangney
CC
, Wang
Y
, Sacks
FM
, Barnes
LL
, Bennett
DA
, MIND diet slows cognitive decline with aging
. Alzheimers Dement
. 2015 Sep
;11
(9
):1015
–22
. .9.
Salari-Moghaddam
A
, Keshteli
AH
, Mousavi
SM
, Afshar
H
, Esmaillzadeh
A
, Adibi
P
. Adherence to the MIND diet and prevalence of psychological disorders in adults
. J Affect Disord
. 2019 Sep 1
;256
:96
–102
. .10.
van den Brink
AC
, Brouwer-Brolsma
EM
, Berendsen
AAM
, van de Rest
O
. The Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diets are associated with less cognitive decline and a lower risk of Alzheimer’s disease: a review
. Adv Nutr
. 2019 Nov 1
;10
(6
):1040
–65
. .11.
Roudsari
NM
, Lashgari
NA
, Momtaz
S
, Farzaei
MH
, Marques
AM
, Abdolghaffari
AH
. Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review
. Daru
. 2019 Dec
;27
(2
):755
–80
. .12.
Khayyatzadeh
SS
, Esmaillzadeh
A
, Saneei
P
, Keshteli
AH
, Adibi
P
. Dietary patterns and prevalence of irritable bowel syndrome in Iranian adults
. Neurogastroenterol Motil
. 2016 Dec
;28
(12
):1921
–33
. .13.
Zito
FP
, Polese
B
, Vozzella
L
, Gala
A
, Genovese
D
, Verlezza
V
, Good adherence to mediterranean diet can prevent gastrointestinal symptoms: a survey from Southern Italy
. World J Gastrointest Pharmacol Ther
. 2016
;7
(4
):564
. .14.
Adibi
P
, Keshteli
AH
, Esmaillzadeh
A
, Afshar
H
, Roohafza
H
, Bagherian-Sararoudi
R
, The study on the epidemiology of psychological, alimentary health and nutrition (SEPAHAN): overview of methodology
. J Res Med Sci
. 2012
;17
(5
):S292
–8
.15.
Wang
ET
, de Koning
L
, Kanaya
AM
. Higher protein intake is associated with diabetes risk in South Asian Indians: the Metabolic Syndrome and Atherosclerosis in South Asians Living in America (MASALA) study
. J Am Coll Nutr
. 2010
;29
(2
):130
–5
. .16.
Keshteli
A
, Esmaillzadeh
A
, Rajaie
S
, Askari
G
, Feinle-Bisset
C
, Adibi
P
. A dish-based semi-quantitative food frequency questionnaire for assessment of dietary intakes in epidemiologic studies in Iran: design and development
. Int J Prev Med
. 2014
;5
(1
):29
.17.
Ghafarpour
M
, Houshiar-Rad
A
, Kianfar
H
, Ghaffarpour
M
. The manual for household measures, cooking yields factors and edible portion of food
. Tehran
: Keshaverzi Press
; 1999
.18.
Aminianfar
A
, Saneei
P
, Nouri
M
, Shafiei
R
, Keshteli
A
, Esmaillzadeh
A
, Validity of self-reported height, weight, body mass index and waist circumference in Iranian adults
. Int J Prevent Med
. Forthcoming 2020
.19.
Buscail
C
, Sabate
JM
, Bouchoucha
M
, Kesse-Guyot
E
, Hercberg
S
, Benamouzig
R
, Western dietary pattern is associated with irritable bowel syndrome in the French NutriNet cohort
. Nutrients
. 2017 Sep 7
;9
(9
):986
. .20.
Koloski
N
, Holtmann
G
, Talley
NJ
. Is there a causal link between psychological disorders and functional gastrointestinal disorders?
Expert Rev Gastroenterol Hepatol
. 2020 Aug 17
;14
:1047
–59
. .21.
Nawawi
KNM
, Belov
M
, Goulding
C
. Low FODMAP diet significantly improves IBS symptoms: an Irish retrospective cohort study
. Eur J Nutr
. 2020 Aug
;59
(5
):2237
–48
. .22.
Mansouri
A
, Rarani
MA
, Fallahi
M
, Alvandi
I
. Irritable bowel syndrome is concentrated in people with higher educations in Iran: an inequality analysis
. Epidemiol Health
. 2017
;39
:e2017005
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
